To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

IV TXA Reduces Peri-Operative Blood Loss & Transfusion Requirement in Periacetabular Osteotomy

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
January 2021

IV TXA Reduces Peri-Operative Blood Loss & Transfusion Requirement in Periacetabular Osteotomy

Vol: 10| Issue: 1| Number:13| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Intravenous tranexamic acid reduces blood loss and transfusion requirements after periacetabular osteotomy

Bone Joint J. 2020 Sep;102-B(9):1151-1157

Contributing Authors:
AE Levack AS McLawhorn E Dodwell K DelPizzo J Nguyen E Sink

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Eighty-one patients scheduled to undergo elective periacetabular osteotomy (PAO) were randomized to receive IV tranexamic acid (TXA; n=40) or intravenous (IV) normal saline (n=41). The primary outcome of interest was total peri-operative calculated blood loss. The secondary outcomes of interest included the incidence of allogeneic transfusion, length of hospital stay, incidence of complications at...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue